Showing results (511-520 of 610) with videos related to
Sort By:
Pageof 61
Scandinavian Journal of Haematology|January 1, 1978
Sensitivity and precision of activated partial thromboplastin time (APTT) methods. A multicenter studyN Refsum, D Collen, H C Godal, et al.Journal of the American College of Cardiology|May 1, 1989
A canine model of coronary artery thrombosis with superimposed high grade stenosis for the investigation of rethrombosis after thrombolysisT Yasuda, H K Gold, J T Fallon, et al.FEBS Letters|November 2, 1999
1,25-Dihydroxyvitamin D(3) induction of the tissue-type plasminogen activator gene is mediated through its multihormone-responsive enhancerP Merchiers, F Bulens, I Stockmans, et al.Circulation|November 1, 1989
Pharmacodynamics of thrombolysis with recombinant tissue-type plasminogen activator. Correlation with characteristics of and clinical outcomes in patients with acute myocardial infarction. The TAMI Study GroupD C Stump, R M Califf, E J Topol, et al.Journal of Thrombosis and Haemostasis : JTH|February 24, 2010
Explanations for coagulation activation after air travelA J M Schreijer, M F Hoylaerts, J C M Meijers, et al.Thrombosis and Haemostasis|August 30, 1985
Increased PA-inhibitor levels in the postoperative period--no cause-effect relation with increased cortisolM F Aillaud, I Juhan-Vague, M C Alessi, et al.Coronary Artery Disease|March 1, 1995
Comparison of a low-molecular-weight heparin (nadroparin calcium) and unfractionated heparin as adjunct to coronary thrombolysis with alteplase and aspirin in dogsL Jun, J Arnout, P Vanhove, et al.Journal of the American College of Cardiology|July 1, 1986
Coronary thrombolysis by intravenous infusion of recombinant single chain urokinase-type plasminogen activator or recombinant urokinase in baboons: effect on regional blood flow, infarct size and hemostasisW Flameng, J Vanhaecke, D C Stump, et al.The Journal of Biological Chemistry|October 25, 1990
Structural requirements for the extracellular interaction of plasminogen activator inhibitor 1 with endothelial cell matrix-associated vitronectinK T Preissner, J Grulich-Henn, H J Ehrlich, et al.Circulation|February 1, 1989
Synergistic combinations of recombinant human tissue-type plasminogen activator and human single-chain urokinase-type plasminogen activator. Effect on thrombolysis and reocclusion in a canine coronary artery thrombosis model with high-grade stenosisA A Ziskind, H K Gold, T Yasuda, et al.Pageof 61